Literature DB >> 3804454

Platelet-activating factor in late asthmatic response.

T Nakamura, Y Morita, M Kuriyama, K Ishihara, K Ito, T Miyamoto.   

Abstract

The role of platelet-activating factor (PAF) in the late asthmatic responses was studied. The concentrations of lyso-form of PAF in plasma were measured at 0 and 20 min, and 6 and 24 h after the antigen inhalation challenge among patients with bronchial asthma. PAF activities were measured by their aggregating ability of washed rabbit platelets after acetylation of lyso-PAF into the biological active form of PAF, when there were no detectable amounts of PAF in plasma. The concentrations of lyso-PAF were found to be significantly increased in patients with the late asthmatic response compared with patients with the single immediate response at 6 h after the antigen challenge. In contrast, lyso-PAF levels were not significantly different at 20 min after the antigen challenge between these two groups. PAF inactivator activity in plasma increased when there was a decrease in the lyso-PAF level. These results suggest that PAF may participate in the late asthmatic response and may provide a new insight into the pathogenesis and the treatment of bronchial asthma.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3804454     DOI: 10.1159/000234290

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  10 in total

1.  Platelet-activating factor (PAF) in allergic diseases: inhibitory effects of anti-allergic drugs, ketotifen and three kampo medicines on PAF production.

Authors:  T Nakamura; M Kuriyama; K Ishihara; Y Matsumura; T Miyamoto
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

2.  Eosinophil accumulation in pulmonary airways of guinea-pigs induced by exposure to an aerosol of platelet-activating factor: effect of anti-asthma drugs.

Authors:  S Sanjar; S Aoki; K Boubekeur; I D Chapman; D Smith; M A Kings; J Morley
Journal:  Br J Pharmacol       Date:  1990-02       Impact factor: 8.739

3.  Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthma.

Authors:  D M Stafforini; T Numao; A Tsodikov; D Vaitkus; T Fukuda; N Watanabe; N Fueki; T M McIntyre; G A Zimmerman; S Makino; S M Prescott
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

4.  Effect of platelet activating factor on formation and composition of airway fluid in the guinea-pig trachea.

Authors:  D F Rogers; E W Alton; B Aursudkij; P Boschetto; A Dewar; P J Barnes
Journal:  J Physiol       Date:  1990-12       Impact factor: 5.182

5.  Lipoxygenase metabolites mediate increased airways responsiveness to histamine after acute platelet activating factor exposure in the guinea-pig.

Authors:  G P Anderson; M R Fennessy
Journal:  Agents Actions       Date:  1988-06

6.  Early bronchial hyperresponsiveness following injection of sephadex beads in the guinea pig: involvement of platelet activating factor and thromboxane A2.

Authors:  D M Conroy; P Sirois
Journal:  Inflammation       Date:  1999-10       Impact factor: 4.092

7.  Inhibitory effect of oral WEB 2086, a novel selective PAF-acether antagonist, on ex vivo platelet aggregation.

Authors:  W S Adamus; H Heuer; C J Meade; G Frey; H M Brecht
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

8.  Increased airways responsiveness to histamine induced by platelet activating factor in the guinea-pig: possible role of lipoxygenase metabolites.

Authors:  G P Anderson; H L White; M R Fennessy
Journal:  Agents Actions       Date:  1988-06

9.  Platelet-activating factor type activity in plasma from patients with septicemia and other diseases.

Authors:  H O Heuer; H Darius; H F Lohmann; J Meyer; M Schierenberg; N Treese
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

10.  Antigen-induced generation of lyso-phospholipids in human airways.

Authors:  F H Chilton; F J Averill; W C Hubbard; A N Fonteh; M Triggiani; M C Liu
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.